The primary objective of this study was to investigate whether PD with different mutations (LRRK2-PD, GBA-PD, or SNCA-PD) exhibit distinct serum NfL levels, both at baseline and during longitudinal change. The gene discussed is LRRK2; the disease is Parkinson disease.